Biogen lobbies on its own behalf. For Q3 2026 it reported $880K across 1 client report and lists 8 lobbyists across its filings. Issues include Health Issues, Medicare/Medicaid, Pharmacy and Taxation/Internal Revenue Code.
| Client | Reported | Issues |
|---|---|---|
| BIOGEN | $880K | Health Issues, Medicare/Medicaid, Pharmacy |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $3.40M | 1 |
| 2025 | $4.16M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.